Page Information

Title:	AbVance II: focus on developability risk prediction of antibody drug candidates
Owner:	IT Support
Creator:	IT Support	Jan 03, 2017
Last Changed by:	Richard Norman (Unlicensed)	Nov 09, 2018
Tiny Link: (useful for email)	https://pistoiaalliance.atlassian.net/wiki/x/BoCABQ
Export As:	Word · PDF

Children (11)
    Page: 2018-05-15 Project Team Meeting - Agenda & Minutes
    Page: Action & Decision log
    Page: Approach
    Page: Biologics database collaboration
    Page: Meeting notes
    Page: Outstanding Questions
    Page: Plans
    Page: Risk assessment
    Page: Scope
    Page: The team

There are no labels assigned to this page.

Time	Editor
Nov 09, 2018 14:39	Richard Norman (Unlicensed)	View Changes
Nov 09, 2018 13:36	Richard Norman (Unlicensed)	View Changes
Oct 26, 2018 14:51	Richard Norman (Unlicensed)	View Changes
Oct 23, 2018 08:47	Richard Norman (Unlicensed)	View Changes
Oct 19, 2018 14:55	Richard Norman (Unlicensed)

External Links (1)
    www.pnas.org/content/114/5/944

Public (8)     Page: Scope     Page: Plans     Page: The team     Page: Risk assessment     Page: Approach     Page: Biologics database collaboration     Page: Outstanding Questions     Page: AbVance II: focus on developability risk prediction of antibody drug candidates